New York City, NY -- (SBWIRE) -- 01/15/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Gray Fox Petroleum Corp (OTCBB:GFOX), Terra Tech Corp (OTCBB:TRTC), Cannabis Science Inc (OTCMKTS:CBIS), RXi Pharmaceuticals Corp (OTCMKTS:RXII)
Gray Fox Petroleum Corp (OTCBB:GFOX) gained 15.03% recently, while trading on 312,381 shares at the price of $1.11. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.50 and was moved to its maximum level of $1.22.The stock changed hands in a range of $1.06 to $1.11, bringing its market capitalization at about $38.92 million.
Will GFOX Continue To Move Higher? Find Out Here
Terra Tech Corp (OTCBB:TRTC) declined 4.11% recently, in the current trading session, at $0.350 with a total volume of 6.46 million shares. The stock, on average, trades on a volume of 6.29 million shares. In the past 52 weeks, the share price has not declined below $0.06 and above $0.66.It floated in a range of $0.30 to $0.39 during the recent trading session.Its market capitalization now moved to about $43.87 million. Terra Tech Corp., formerly Private Secretary, Inc., through its subsidiary GrowOp Technology Ltd. (GrowOp Technology) specializes in controlled agricultural technologies. The company integrates breed hydroponic equipment with technology to create solutions for the cultivation of indoor agriculture.
Will TRTC Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Cannabis Science Inc (OTCMKTS:CBIS) recently recorded a fall of -4.55% and was moving within a range of $0.11-$0.12. Its current trading price is $0.116. The share price hit its 52-week low of $0.03 and $0.19 was the best price. The stock completed the day with a total volume of 11.50 million shares, versus an average volume of 25.96 million shares. Cannabis Science, Inc. is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
Is it the Right to Grab CBIS after the Recent Slump? Get Free Trend Analysis Here
RXi Pharmaceuticals Corp (OTCMKTS:RXII) added 13.66% in its current trading activity, bringing its market capitalization around $66.95 million. The total number of shares that changed hands during the current session up till now was 195,895 shares, as compared to average trading volume of 123,680 shares. The share price after opening at $5.18 made a high of $5.78 and hovered above $5.11, while its recent trading price was $5.74. RXi Pharmaceuticals Corporation (RXi) is a development-stage company. The Company is a biotechnology company focused on discovering, developing and commercializing therapies addressing medical needs using RNA interference (RNAi)-targeted technologies.
Why Should Investors Buy RXII After The Recent Gain? Just Go Here and Find Out
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)